MPM Capital
Michael Ehlers is an accomplished entrepreneur and executive with extensive experience in the biotechnology sector. As the Founder, President, and Chief Executive Officer of Ascidian Therapeutics, Michael also serves as the Founder and Board Chair of the company. Additionally, Michael has co-founded and been a Board Member of both Replicate Bioscience, Inc. and Aulos Bioscience. At ATP (Apple Tree Partners), Michael holds the positions of Chief Scientific Officer and General Partner, as well as Chief Scientific Officer and Venture Partner, demonstrating a strong leadership role in advancing scientific and business ventures.
This person is not in the org chart
This person is not in any teams
MPM Capital
MPM Capital is a healthcare investment firm with over two decades of experience founding and investing in life-sciences companies that seek to translate scientific innovations into cures for major diseases.